| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 15% | $84,305,460 | 6,826,353 | BlackRock, Inc. | 31 Mar 2025 | |||
| T. Rowe Price Investment Management, Inc. | 10% | +25% | $54,487,048 | +$11,050,221 | 4,713,494 | +25% | T. Rowe Price Investment Management, Inc. | 30 Sep 2025 |
| VANGUARD GROUP INC | 7.4% | -23% | $39,595,474 | -$12,018,724 | 3,425,214 | -23% | The Vanguard Group | 30 Sep 2025 |
| ARMISTICE CAPITAL, LLC | 6.9% | +30% | $38,304,000 | +$8,379,000 | 3,200,000 | +28% | Armistice Capital, LLC | 31 Dec 2025 |
| DIMENSIONAL FUND ADVISORS LP | 4.6% | -10% | $24,230,152 | -$2,191,104 | 2,157,531 | -8.3% | Dimensional Fund Advisors LP | 31 Dec 2025 |
As of 31 Dec 2025, 264 institutional investors reported holding 45,291,446 shares of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS). This represents 98% of the company’s total 46,444,122 outstanding shares.
The largest institutional shareholders of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) together control 79% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 15% | 6,750,911 | -1.2% | 0% | $75,812,732 |
| T. Rowe Price Investment Management, Inc. | 9.6% | 4,470,622 | -5.2% | 0.03% | $50,206,000 |
| VANGUARD GROUP INC | 7.6% | 3,526,785 | +3% | 0% | $39,605,795 |
| ARMISTICE CAPITAL, LLC | 6.9% | 3,200,000 | +28% | 0.88% | $35,936,000 |
| DIMENSIONAL FUND ADVISORS LP | 4.6% | 2,157,531 | -8.3% | 0.01% | $24,229,230 |
| STATE STREET CORP | 4.2% | 1,954,785 | +2.8% | 0% | $21,952,236 |
| BROWN ADVISORY INC | 4.2% | 1,935,802 | -13% | 0.03% | $21,739,057 |
| D. E. Shaw & Co., Inc. | 2.6% | 1,210,456 | -6.8% | 0.01% | $13,593,421 |
| MORGAN STANLEY | 2.4% | 1,094,036 | +31% | 0% | $12,286,035 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.3% | 1,084,504 | +1.6% | 0% | $12,179,689 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.2% | 1,040,666 | +20% | 0% | $11,686,679 |
| ACADIAN ASSET MANAGEMENT LLC | 2.1% | 952,975 | +123% | 0.02% | $10,696,000 |
| CLARK ESTATES INC/NY | 1.9% | 888,880 | +13% | 2.4% | $9,982,122 |
| MILLENNIUM MANAGEMENT LLC | 1.6% | 731,900 | -18% | 0.01% | $8,219,237 |
| AQR CAPITAL MANAGEMENT LLC | 1.6% | 727,696 | -20% | 0% | $8,172,027 |
| Qube Research & Technologies Ltd | 1.5% | 702,915 | -3.4% | 0.01% | $7,893,735 |
| ExodusPoint Capital Management, LP | 1.3% | 586,485 | +61% | 0.07% | $6,586,227 |
| AMERIPRISE FINANCIAL INC | 1.3% | 582,585 | -1.5% | 0% | $6,542,430 |
| DIAMOND HILL CAPITAL MANAGEMENT INC | 1.1% | 509,702 | +17% | 0.03% | $5,723,953 |
| CITADEL ADVISORS LLC | 1% | 478,620 | -17% | 0% | $5,374,902 |
| NORTHERN TRUST CORP | 1% | 473,281 | -3.8% | 0% | $5,314,945 |
| GOLDMAN SACHS GROUP INC | 0.97% | 451,389 | -0.42% | 0% | $5,069,098 |
| UBS Group AG | 0.89% | 415,107 | +7.9% | 0% | $4,661,651 |
| FMR LLC | 0.79% | 365,545 | +35% | 0% | $4,105,073 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.67% | 311,479 | +7.2% | 0.07% | $3,497,909 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 45,291,446 | $508,727,504 | +$5,029,470 | $11.23 | 264 |
| 2025 Q3 | 44,941,446 | $519,511,070 | -$420,999 | $11.56 | 270 |
| 2025 Q2 | 44,711,937 | $547,287,477 | +$14,185,298 | $12.24 | 279 |
| 2025 Q1 | 43,396,946 | $623,274,490 | -$6,741,914 | $14.33 | 275 |
| 2024 Q4 | 43,159,764 | $687,053,030 | -$348,352 | $15.92 | 253 |
| 2024 Q3 | 42,887,071 | $1,030,142,636 | +$14,845,110 | $24.03 | 257 |
| 2024 Q2 | 42,331,138 | $843,184,184 | -$19,844,468 | $19.92 | 254 |
| 2024 Q1 | 43,394,488 | $863,829,555 | -$12,610,070 | $19.91 | 255 |
| 2023 Q4 | 43,936,227 | $986,177,329 | +$6,301,621 | $22.43 | 261 |
| 2023 Q3 | 43,653,986 | $883,886,301 | -$24,810,694 | $20.22 | 251 |
| 2023 Q2 | 44,367,274 | $1,134,245,375 | +$6,577,133 | $25.56 | 267 |
| 2023 Q1 | 43,807,927 | $1,302,667,520 | +$18,327,231 | $29.74 | 278 |
| 2022 Q4 | 43,474,984 | $1,176,504,936 | +$5,615,427 | $27.06 | 274 |
| 2022 Q3 | 43,372,951 | $944,662,406 | -$2,543,596 | $21.78 | 218 |
| 2022 Q2 | 43,323,037 | $1,184,314,252 | -$13,685,481 | $27.34 | 227 |
| 2022 Q1 | 43,970,678 | $1,472,010,622 | +$2,331,652 | $33.50 | 252 |
| 2021 Q4 | 43,852,763 | $1,519,830,657 | +$2,873,575 | $34.67 | 251 |
| 2021 Q3 | 43,701,330 | $1,363,473,910 | -$25,618,497 | $31.20 | 229 |
| 2021 Q2 | 44,393,122 | $1,614,401,834 | +$1,417,948 | $36.37 | 239 |
| 2021 Q1 | 44,092,800 | $1,928,597,642 | -$45,329,737 | $43.74 | 251 |
| 2020 Q4 | 45,157,960 | $2,071,803,289 | -$25,305,709 | $45.88 | 240 |
| 2020 Q3 | 45,956,879 | $1,526,673,060 | -$9,601,150 | $33.22 | 230 |
| 2020 Q2 | 46,293,558 | $1,360,488,473 | +$21,246,989 | $29.39 | 233 |
| 2020 Q1 | 45,529,610 | $1,226,168,208 | -$38,883,046 | $26.93 | 219 |
| 2019 Q4 | 45,819,566 | $1,543,944,370 | +$20,782,780 | $33.70 | 247 |
| 2019 Q3 | 45,225,869 | $1,694,273,669 | -$5,936,111 | $37.46 | 250 |
| 2019 Q2 | 45,322,055 | $1,976,386,420 | +$18,591,188 | $43.61 | 277 |
| 2019 Q1 | 45,113,689 | $1,925,520,203 | +$46,047,746 | $42.68 | 296 |
| 2018 Q4 | 43,999,885 | $1,970,607,092 | -$23,436,579 | $44.79 | 305 |
| 2018 Q3 | 42,817,781 | $2,932,605,954 | +$2,861,296,937 | $68.50 | 350 |
| 2018 Q2 | 1,040,879 | $59,567,007 | +$59,548,000 | $57.26 | 34 |
| 2018 Q1 | 332 | $15,299 | +$599 | $46.08 | 2 |
| 2017 Q4 | 319 | $14,732 | $46.18 | 2 | |
| 2017 Q3 | 319 | $14,364 | -$1,254 | $45.03 | 2 |
| 2017 Q2 | 347 | $13,630 | $39.28 | 3 | |
| 2017 Q1 | 347 | $13,217 | -$457 | $38.08 | 3 |
| 2016 Q4 | 359 | $13,276 | -$2,737 | $36.98 | 3 |
| 2016 Q3 | 432 | $14,973 | -$1,629 | $34.66 | 2 |
| 2016 Q2 | 479 | $15,577 | -$6,000 | $32.52 | 2 |
| 2016 Q1 | 611 | $19,762 | $28.73 | 3 |